Medifast Q4 Earnings Call Highlights

Management said the company’s clinically supported system is intended to address metabolic dysfunction and improve body composition, energy, and overall health. Chard cited results from a 16-week clinical study of the company’s “5-in-1 metabolic plan,” saying participants reduced visceral fat by 14% while retaining 98% of lean mass and experienced clinically significant weight loss.Chard described the past two years as a period of transformation amid disruption in the weight loss industry driven by the rapi ...